After comparing the expression level of the tumour and non-tumour tissues, the results indicated that RBM17 was overexpressed in most cancers, and only HCC manifested significantly different expression (Fig 1A, P-value < 0.05). This evidence concerns the gene RBM17 and hepatocellular carcinoma.